REG - FIL LimitedMedtronic, Inc.Covidien plc - Form 8.3 - COVIDIEN PLC <Origin Href="QuoteRef">COV.N</Origin> <Origin Href="QuoteRef">MDT.N</Origin>

MedtronicAnnouncement

29/10/2014 15:01

RNS Number : 9479P
FIL Limited
25 August 2014
FORM 8.3
 IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2007 (AS AMENDED)
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1)
 FMR LLC and/or one or more of its direct or indirect subsidiaries
And
FIL Limited and/or one or more of its direct and indirect subsidiaries
Company dealt in
COVIDIEN PLC
Class of relevant security to which the dealings being disclosed relate(Note 2)
Ordinary shares
Date of dealing
22-August-14
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security
dealt in(Note 3)
Long
Short
Number (%)
Number (%)
(1) Relevant securities 
20,560,960 4.55

(2) Derivatives (other than options)
 
 
(3) Options and agreements to purchase/sell
 
 
Total
20,560,960 4.55
 
b) Interests and short positions in relevant securities of the company, other than the
class dealt in(Note 3)
Class of relevant security:
Long
Short
Number (%)
Number (%)
(1) Relevant securities 
 
 
(2) Derivatives (other than options)
 
 
(3) Options and agreements to purchase/sell
 
 
Total
 
 
3. DEALINGS(Note 4)
(a) Purchases and sales
Purchase/sale
Number of securities
Price per unit
Buy
1,800
88.6078 USD/ Share
Sale
500
88.6040 USD/ Share
Buy
1
88.2600 USD/ Share
Buy
13
89.0000 USD/ Share
Buy
94
89.1200 USD/ Share
Buy
114
89.0100 USD/ Share
Sale
130
89.0000 USD/ Share
Sale
3
88.9900 USD/ Share
Sale
4
89.1000 USD/ Share
Sale
7
88.9800 USD/ Share
(b) Derivatives transactions (other than options transactions)
Product name, 
e.g. CFD
Nature of transaction (Note 6)
Number of securities (Note 7)
Price per unit (Note 5)




(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name,
e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise
price 
Type, e.g. American, European etc.
Expiry 
date
Option money
paid/received per unit (Note 5) 







(ii) Exercising
Product name, e.g. call option
Number of securities 
Exercise price per unit (Note 5)


(d) Other dealings (including transactions in respect of new securities)(Note 4)
Nature of transaction (Note 8)
Details
Price per unit (if applicable)(Note 5)


4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. 
Is a Supplemental Form 8 attached?(Note 9)NO
Date of disclosure
25 August 2014
Contact name
Nevelina Rousseva-Gasnier
Telephone number
+44 (0)1737 837216
If a connected EFM, name of offeree/offeror with which connected
N/A
If a connected EFM, state nature of connection (Note 10)
N/A

This information is provided by RNS
The company news service from the London Stock Exchange
  END
ISELLFEVTDIEFIS